Xanodyne Receives Approval From The U.S. Food And Drug Administration For ZIPSOR(TM) (diclofenac Potassium) Liquid Filled Capsules
Submitted by Robert Lawrence on Thursday, 18 June 2009No Comment
Xanodyne Pharmaceuticals, Inc. announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Zipsor (diclofenac potassium) Liquid Filled Capsules, a new treatment option indicated for relief of mild to moderate acute pain in adults (18 years of age or older). “Zipsor is a drug with several unique features,” said Gary A. Shangold, Chief Medical Officer of Xanodyne.
Leave a comment!